Skip to main content
. 2021 Jan 6;29(4):687–698. doi: 10.1038/s41431-020-00782-w

Fig. 3. Incorporating Dynamic Consent into the existing Australian Genomics study participant pathway.

Fig. 3

Pathway A reflects the current implementation strategy. Pathway B is also HREC-approved, but barriers experienced include lack of access to tablets or computers in the clinic and inability to pre-assign participant Study ID numbers, which is not compatible with ethics requirements and standard study practice.